facebook linkedin twitter

FDA Revokes Emergency Use of Hydroxychloroquine to Fight Coronavirus

June 15, 2020 by Dan McCue
A chemist displays hydroxychloroquine tablets. U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19. The Food and Drug Administration said Monday, June 15 that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. (AP Photo/Manish Swarup, File)

WASHINGTON – The Food and Drug Administration revoked its emergency authorization of hydroxychloroquine and chloroquine for treating COVID-19 as evidence mounts that the drugs don’t work and can cause serious side effects.

“We’ve made clear throughout the public health emergency that our actions will be guided by science and that our decisions may evolve as we learn more about the SARS-CoV-2 virus, review the latest data, and consider the balance of risks versus benefits of treatments for COVID-19,” said Dr. Anand Shah, FDA deputy commissioner for Medical and Scientific Affairs.

Dr. Patrizia Cavazzoni, acting director of the FDA’s Center for Drug Evaluation, said while additional clinical trials will continue to evaluate the potential benefit of these drugs in treating or preventing COVID-19, “we determined the emergency use authorization was no longer appropriate.”

Cavazzoni explained the decision to revoke the drugs emergency approval was taken following “a rigorous assessment” by scientists at the Center for Drug Evaluation and Research.

“We remain committed to using every tool at our disposal in collaboration with innovators and researchers to provide sick patients timely access to appropriate new therapies,” Cavazzoni said. “Our decisions will always be based on objective and rigorous evaluation of the scientific data. This will never change.”

President Donald Trump had aggressively pushed the drug beginning in the first weeks of the outbreak and stunned medical professionals when he revealed he took the drug preemptively against infection.

All this despite the fact no large studies have found the drugs safe or effective for preventing or treating COVID-19.

Last week, a National Institutes of Health panel of experts revised its recommendations to specifically recommend against the drug’s use except in formal studies

The decades-old drugs, also prescribed for lupus and rheumatoid arthritis, can cause heart rhythm problems, severely low blood pressure and muscle or nerve damage.

The FDA’s formal statement on the matter said, “in light of ongoing serious cardiac adverse events and other potential serious side effects, the known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the authorized use.”

The agency’s decision means that shipments of the drugs obtained by the federal government will no longer be distributed to state and local health authorities for use against the coronavirus. 

Health

November 26, 2021
by Dan McCue
US Restricts Travel From 8 Countries in Response to Omicron Variant

WASHINGTON - The Biden Administration on Friday imposed air travel restrictions on eight African nations in response to a new... Read More

WASHINGTON - The Biden Administration on Friday imposed air travel restrictions on eight African nations in response to a new COVID strain first detected in South Africa. The new travel restrictions, which go into effect Monday, apply to citizens of South Africa, Botswana, Zimbabwe, Namibia, Lesotho,... Read More

World Takes Action as New Variant Emerges in Southern Africa

BRUSSELS (AP) — A slew of nations moved to stop air travel from southern Africa on Friday, and stocks plunged... Read More

BRUSSELS (AP) — A slew of nations moved to stop air travel from southern Africa on Friday, and stocks plunged in Asia and Europe in reaction to news of a new, potentially more transmissible COVID-19 variant. "The last thing we need is to bring in a... Read More

November 23, 2021
by Dan McCue
House and Senate Democrats Seek to Protect Access to Birth Control Act

WASHINGTON — More than 100 Democrats in the House and Senate are urging their colleagues to help them guarantee a... Read More

WASHINGTON — More than 100 Democrats in the House and Senate are urging their colleagues to help them guarantee a woman’s timely access to birth control at her local pharmacy. The legislation, the Access to Birth Control Act, was reintroduced in the Senate Tuesday by Sens.... Read More

Biden to Have Routine Colonoscopy, Transfer Power to Harris

BETHESDA, Md. (AP) — President Joe Biden will briefly transfer power to Vice President Kamala Harris on Friday when he... Read More

BETHESDA, Md. (AP) — President Joe Biden will briefly transfer power to Vice President Kamala Harris on Friday when he undergoes a “routine colonoscopy" at Walter Reed National Military Medical Center, the White House said. Biden drove early Friday to the medical center in the Washington... Read More

November 17, 2021
by Dan McCue
Biden Administration Suspends Enforcement of Vaccine Mandate

WASHINGTON — The Biden administration on Wednesday suspended enforcement of a vaccine mandate on private companies with 100 or more... Read More

WASHINGTON — The Biden administration on Wednesday suspended enforcement of a vaccine mandate on private companies with 100 or more employees. The decision, which was carried out through the Occupational Safety and Health Administration, comes less than a week after the 5th U.S. Circuit Court of... Read More

November 17, 2021
by Alexa Hornbeck
Health Officials Address What To Do If You Lose Your Vaccination Card

WASHINGTON —Many public health departments across the country are experiencing increasing calls from individuals who have lost their vaccination cards... Read More

WASHINGTON —Many public health departments across the country are experiencing increasing calls from individuals who have lost their vaccination cards and are seeking a replacement. "Our department receives, on average, 60 requests for replacement vaccination cards each week. This number has remained steady for the last... Read More

News From The Well
scroll top